BCG Oncology, PC Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2008
NCT00782587
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

BCG Oncology, PC